Exelixis, Inc. (EXEL)
71.72
+2.15
(+3.09%)
USD |
NASDAQ |
Nov 09, 16:00
71.72
0.00 (0.00%)
After-Hours: 17:30
Exelixis Gross Profit (Annual) : 2.236B for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 2.236B |
| December 31, 2024 | 2.092B |
| December 31, 2023 | 1.758B |
| December 31, 2022 | 1.553B |
| December 31, 2021 | 1.382B |
| December 31, 2020 | 951.27M |
| December 31, 2019 | 934.68M |
| December 31, 2018 | 827.48M |
| December 31, 2017 | 437.61M |
| December 31, 2016 | 185.10M |
| December 31, 2015 | 33.48M |
| December 31, 2014 | 20.18M |
| December 31, 2013 | 27.07M |
| December 31, 2012 | 0.00 |
| December 31, 2011 | 282.81M |
| Date | Value |
|---|---|
| December 31, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| December 31, 2004 | 0.00 |
| December 31, 2003 | 0.00 |
| December 31, 2002 | 0.00 |
| December 31, 2001 | 25.80M |
| December 31, 2000 | -23.96M |
| December 31, 1999 | -11.14M |
| December 31, 1998 | -9.824M |
| December 31, 1997 | -8.223M |
| December 31, 1996 | -4.12M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| BioMarin Pharmaceutical, Inc. | 2.505B |
| Alnylam Pharmaceuticals, Inc. | 3.032B |
| Cytokinetics, Inc. | 77.91M |
| Gilead Sciences, Inc. | 23.22B |
| Ionis Pharmaceuticals, Inc. | 915.36M |